Medifast (MED)

Common Stock
Sell: $9.40|Buy: $10.38|Change: 0.32 (-3.04%)

Open 

$10.37


Previous close 

$10.52


Trade high 

$10.3836


Volume 

195,585


Year high 

$15.46


Year low 

$9.22


Dividend yield 


Market capitalisation 

$112.11 mn


P/E ratio 

531.00


ISIN 

US58470H1014


Share price

Dividends

PreviousLatest
Record date27/06/202319/09/2023
Ex-dividend date26/06/202318/09/2023
Payment date08/08/202307/11/2023
Amount$1.65$1.65

Performance 06/04/2026

1D | 1M | 3M | 1Y | 3Y ann | 5Y ann | 10Y ann


Total return (%)
Medifast+ 1.54
More...

Company profile

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. The company provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. The company is focused on offering talent to Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

Sector 

Consumer Cyclical


AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.

© Copyright 2026 AJ Bell. All rights reserved.